Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era (vol 20, pg 58, 2018)

被引:3
|
作者
Jing, Yankang [1 ,2 ,3 ]
Bian, Yuemin [1 ,2 ,3 ]
Hu, Ziheng [1 ,2 ,3 ]
Wang, Lirong [1 ,2 ,3 ]
Xie, Xiang-Qun [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci & Computat Chem, Genom Screening Ctr, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, NIH Natl Ctr Excellence Computat Drug Abuse Res, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA 15261 USA
[5] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA
来源
AAPS JOURNAL | 2018年 / 20卷 / 04期
关键词
D O I
10.1208/s12248-018-0243-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The name of the corresponding author should be 'Xiang-Qun Xie', rather than 'Xiang-Qun Sean Xie'.
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Natural product drug discovery in the artificial intelligence era
    Saldivar-Gonzalez, F. I.
    Aldas-Bulos, V. D.
    Medina-Franco, J. L.
    Plisson, F.
    CHEMICAL SCIENCE, 2022, 13 (06) : 1526 - 1546
  • [22] Rethinking drug design in the artificial intelligence era
    Petra Schneider
    W. Patrick Walters
    Alleyn T. Plowright
    Norman Sieroka
    Jennifer Listgarten
    Robert A. Goodnow
    Jasmin Fisher
    Johanna M. Jansen
    José S. Duca
    Thomas S. Rush
    Matthias Zentgraf
    John Edward Hill
    Elizabeth Krutoholow
    Matthias Kohler
    Jeff Blaney
    Kimito Funatsu
    Chris Luebkemann
    Gisbert Schneider
    Nature Reviews Drug Discovery, 2020, 19 : 353 - 364
  • [23] Rethinking drug design in the artificial intelligence era
    Schneider, Petra
    Walters, W. Patrick
    Plowright, Alleyn T.
    Sieroka, Norman
    Listgarten, Jennifer
    Goodnow, Robert A., Jr.
    Fisher, Jasmin
    Jansen, Johanna M.
    Duca, Jose S.
    Rush, Thomas S.
    Zentgraf, Matthias
    Hill, John Edward
    Krutoholow, Elizabeth
    Kohler, Matthias
    Blaney, Jeff
    Funatsu, Kimito
    Luebkemann, Chris
    Schneider, Gisbert
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (05) : 353 - 364
  • [24] Artificial intelligence and machine learning in drug discovery and development
    Patel V.
    Shah M.
    Intelligent Medicine, 2022, 2 (03): : 134 - 140
  • [25] Artificial intelligence and machine learning for drug discovery, design and repurposing: methods and applications
    Zheng, Pan
    Zeng, Xiangxiang
    Wang, Xun
    Ding, Pingjian
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [26] Advancing Drug Discovery via Artificial Intelligence (vol 40, pg 592, 2019)
    Chan, H. C. Stephen
    Shan, Hanbin
    Dahoun, Thamani
    Vogel, Horst
    Yuan, Shuguang
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (10) : 801 - 801
  • [27] Artificial intelligence approaches for rational drug design and discovery
    Duch, Wlodzislaw
    Swaminathan, Karthikeyan
    Meller, Jaroslaw
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (14) : 1497 - 1508
  • [28] Morphological profiling for drug discovery in the era of deep learning
    Tang, Qiaosi
    Ratnayake, Ranjala
    Seabra, Gustavo
    Jiang, Zhe
    Fang, Ruogu
    Cui, Lina
    Ding, Yousong
    Kahveci, Tamer
    Bian, Jiang
    Li, Chenglong
    Luesch, Hendrik
    Li, Yanjun
    BRIEFINGS IN BIOINFORMATICS, 2024, 25 (04)
  • [29] Big Data and Artificial Intelligence in Drug Discovery for Gastric Cancer: Current Applications and Future Perspectives
    Nguyen, Mai Hanh
    Tran, Ngoc Dung
    Le, Nguyen Quoc Khanh
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [30] Role of Artificial Intelligence and Machine Learning in Sustainable Drug Discovery
    Sahrawat, Tammanna Ravee
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2024, 67